Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Oncogene ; 27(8): 1167-74, 2008 Feb 14.
Article in English | MEDLINE | ID: mdl-17700523

ABSTRACT

There are three major isoforms of BAG-1 in mammalian cells, termed BAG-1L (p50), BAG-1M (p46) and BAG-1S (p36) that function as pro-survival proteins and are associated with tumorigenesis and chemoresistance. Initiation of BAG-1 protein synthesis can occur by both cap-dependent and cap-independent mechanisms and it has been shown that synthesis of BAG-1S is dependent upon the presence of an internal ribosome entry segment (IRES) in the 5'-UTR of BAG-1 mRNA. We have shown previously that BAG-1 IRES-meditated initiation of translation requires two trans-acting factors poly (rC) binding protein 1 (PCBP1) and polypyrimidine tract binding protein (PTB) for function. The former protein allows BAG-1 IRES RNA to attain a structure that permits binding of the ribosome, while the latter protein appears to be involved in ribosome recruitment. Here, we show that the BAG-1 IRES maintains synthesis of BAG-1 protein following exposure of cells to the chemotoxic drug vincristine but not to cisplatin and that this is brought about, in part, by the relocalization of PTB and PCBP1 from the nucleus to the cytoplasm.


Subject(s)
DNA-Binding Proteins/biosynthesis , DNA-Binding Proteins/genetics , Gene Expression Regulation, Neoplastic/drug effects , Oxidative Stress , RNA, Messenger/metabolism , Ribosomes/genetics , Transcription Factors/biosynthesis , Transcription Factors/genetics , Cisplatin/toxicity , HeLa Cells , Humans , Oxidative Stress/drug effects , RNA, Messenger/genetics , Ribosomes/drug effects , Tubulin Modulators/toxicity , Vincristine/toxicity
2.
Cell Death Differ ; 12(6): 571-84, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15900314

ABSTRACT

Recent studies have identified several mechanistic links between the regulation of translation and the process of apoptosis. Rates of protein synthesis are controlled by a wide range of agents that induce cell death, and in many instances, the changes that occur to the translational machinery precede overt apoptosis and loss of cell viability. The two principal ways in which factors required for translational activity are modified prior to and during apoptosis involve (i) changes in protein phosphorylation and (ii) specific proteolytic cleavages. In this review, we summarise the principal targets for such regulation, with particular emphasis on polypeptide chain initiation factors eIF2 and eIF4G and the eIF4E-binding proteins. We indicate how the functions of these factors and of other proteins with which they interact may be altered as a result of activation of apoptosis and we discuss the potential significance of such changes for translational control and cell growth regulation.


Subject(s)
Apoptosis , Eukaryotic Initiation Factors/metabolism , Animals , Humans , Protein Processing, Post-Translational , RNA, Messenger/genetics , RNA, Messenger/metabolism
3.
Oncogene ; 20(30): 4095-100, 2001 Jul 05.
Article in English | MEDLINE | ID: mdl-11494137

ABSTRACT

BAG-1 (also known as RAP46/HAP46) was originally identified as a 46 kDa protein that bound to and enhanced the anti-apoptotic properties of Bcl-2. BAG-1 exists as three major isoforms (designated p50, p46 and p36 or BAG-1L, BAG-1M and BAG-1S respectively) and one minor isoform (p29), which are translated from a common transcript. The differing amino terminus determines both the intracellular location and the repertoire of binding partners of the isoforms which play different roles in a variety of cellular processes including signal transduction, heat shock, apoptosis and transcription. Although in vitro data suggest that the four BAG-1 isoforms are translated by leaky scanning, the patterns of isoform expression in vivo, especially in transformed cells, do not support this hypothesis. We have performed in vivo analysis of the BAG-1 5' untranslated region and shown that translation initiation of the most highly expressed isoform (p36/BAG-1S) can occur by both internal ribosome entry and cap-dependent scanning. Following heat shock, when there is a downregulation of cap-dependent translation, the expression of the p36 isoform of BAG-1 is maintained by internal ribosome entry.


Subject(s)
Carrier Proteins/biosynthesis , Hot Temperature , Protein Biosynthesis , Protein Isoforms/biosynthesis , Ribosomes/metabolism , 5' Untranslated Regions , Apoptosis , Base Sequence , Carrier Proteins/genetics , DNA-Binding Proteins , Genes, Reporter , HeLa Cells , Humans , Luciferases/biosynthesis , Luciferases/genetics , Models, Biological , Molecular Sequence Data , Neoplasm Proteins/metabolism , Protein Isoforms/genetics , RNA Caps/physiology , Recombinant Fusion Proteins/biosynthesis , Stress, Physiological/genetics , Stress, Physiological/metabolism , Transcription Factors
4.
Mol Cell Biol ; 21(10): 3364-74, 2001 May.
Article in English | MEDLINE | ID: mdl-11313462

ABSTRACT

It has been reported previously that the 5' untranslated region of the mRNA encoding Apaf-1 (apoptotic protease-activating factor 1) has an internal ribosome entry site (IRES), whose activity varies widely among different cell types. Here it is shown that the Apaf-1 IRES is active in rabbit reticulocyte lysates, provided that the system is supplemented with polypyrimidine tract binding protein (PTB) and upstream of N-ras (unr), two cellular RNA binding proteins previously identified to be required for rhinovirus IRES activity. In UV cross-linking assays and electrophoretic mobility shift assays with individual recombinant proteins, the Apaf-1 IRES binds unr but not PTB; however, PTB binding occurs if unr is present. Over a range of different cell types there is a broad correlation between the activity of the Apaf-1 IRES and their content of PTB and unr. In cell lines deficient in these proteins, overexpression of PTB and unr stimulated Apaf-1 IRES function. This is the first example where an IRES in a cellular mRNA has been shown to be functionally dependent, both in vitro and in vivo, on specific cellular RNA binding proteins. Given the critical role of Apaf-1 in apoptosis, these results have important implications for the control of the apoptotic cascade.


Subject(s)
Genes, ras , Proteins/genetics , RNA-Binding Proteins/genetics , Ribonucleoproteins/genetics , Ribosomes/genetics , Animals , Apoptosis/genetics , Apoptotic Protease-Activating Factor 1 , Cell Death/genetics , Cell Division/genetics , Cell Line , Gene Expression Regulation , Humans , Polypyrimidine Tract-Binding Protein , Transfection
5.
Oncogene ; 19(7): 899-905, 2000 Feb 17.
Article in English | MEDLINE | ID: mdl-10702798

ABSTRACT

The apoptotic protease activating factor (Apaf-1) plays a central role in apoptosis: interaction of this protein with procaspase-9 leads to cleavage and activation of this initiator caspase. In common with other mRNAs whose protein products have a major regulatory function, the 5' untranslated region (UTR) of Apaf-1 is long, G-C rich and has the potential to form secondary structure. We have shown that the 5' UTR of Apaf-1 contains an internal ribosome entry segment, located in a 233 nucleotide region towards the 3' end of the leader, and that the translation initiation of this mRNA occurs only by internal ribosome entry. The Apaf-1 IRES is active in almost all human cell types tested, including Human cervical carcinoma (HeLa), Human liver carcinoma (HepG2), Human breast carcinoma (MCF7), Human embryonic kidney (HK293), African Green Monkey kidney (COS7) and Human lung (MRC5). The Apaf-1 IRES initiates translation as efficiently as the HRV IRES, but is less active than the c-myc IRES. We propose that the Apaf-1 IRES ensures that a constant cellular level of Apaf-1 protein is maintained even under conditions where cap-dependent translation is compromised. Oncogene (2000) 19, 899 - 905.


Subject(s)
Peptide Chain Initiation, Translational , Proteins/genetics , Proteins/metabolism , 5' Untranslated Regions/pharmacology , Animals , Apoptosis/genetics , Apoptotic Protease-Activating Factor 1 , COS Cells , Cell Line , Genes/genetics , Genes, Reporter , Genetic Vectors/genetics , HeLa Cells , Humans , Luciferases/genetics , Luciferases/metabolism , Tumor Cells, Cultured
6.
Nucleic Acids Res ; 28(3): 687-94, 2000 Feb 01.
Article in English | MEDLINE | ID: mdl-10637319

ABSTRACT

The 5' UTR of c -myc mRNA contains an internal ribo-some entry segment (IRES) and consequently, c -myc mRNAs can be translated by the alternative mechanism of internal ribosome entry. However, there is also some evidence suggesting that c -myc mRNA translation can occur via the conventional cap-dependent scanning mechanism. Using both bicistronic and monocistronic mRNAs containing the c- myc 5' UTR, we demonstrate that both mechanisms can contribute to c- myc protein synthesis. A wide range of cell types are capable of initiating translation of c- myc by internal ribosome entry, albeit with different efficiencies. Moreover, our data suggest that the spectrum of efficiencies observed in these cell types is likely to be due to variation in the cellular concentration of non-canonical translation factors. Interestingly, the c -myc IRES is 7-fold more active than the human rhinovirus 2 (HRV2) IRES and 5-fold more active than the encephalomyocarditis virus (EMCV) IRES. However, the protein requirements for the c -myc IRES must differ significantly from these viral IRESs, since an unidentified nuclear event appears to be a pre-requisite for efficient c -myc IRES-driven initiation.


Subject(s)
5' Untranslated Regions/genetics , Cell Nucleus/metabolism , Peptide Chain Initiation, Translational/genetics , Proto-Oncogene Proteins c-myc/genetics , Trans-Activators/metabolism , 5' Untranslated Regions/chemistry , 5' Untranslated Regions/metabolism , Animals , Cell Extracts , Cell Line , Codon, Initiator/genetics , Encephalomyocarditis virus/genetics , Genes/genetics , Genes, Viral/genetics , Humans , Mice , Mice, Inbred BALB C , Molecular Weight , Nucleic Acid Conformation , Organ Specificity , Proto-Oncogene Proteins c-myc/chemistry , Proto-Oncogene Proteins c-myc/metabolism , RNA Caps/genetics , RNA Caps/metabolism , Reticulocytes , Rhinovirus/genetics , Ribosomes/physiology , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL
...